Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results
Acq. announced
Director departure

Aprea Therapeutics, Inc. (APRE) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/24/2023 4 Pamukcu Rifat (Director) has filed a Form 4 on Aprea Therapeutics, Inc.
Txns: Converted 49,280 shares @ $0
Granted 500 shares @ $0
Converted 271,870 shares @ $0
Converted 4,928 options to buy @ $0
Converted 27,187 options to buy @ $0
Granted 2,000 options to buy @ $3.65, valued at $7.3k
08/24/2023 4 Grissinger Michael (Director) has filed a Form 4 on Aprea Therapeutics, Inc.
Txns: Granted 500 shares @ $0
Granted 2,000 options to buy @ $3.65, valued at $7.3k
08/24/2023 4 HENNEMAN JOHN B III (Director) has filed a Form 4 on Aprea Therapeutics, Inc.
Txns: Granted 500 shares @ $0
Granted 2,000 options to buy @ $3.65, valued at $7.3k
08/24/2023 4 Peters Richard (Director) has filed a Form 4 on Aprea Therapeutics, Inc.
Txns: Granted 500 shares @ $0
Granted 2,000 options to buy @ $3.65, valued at $7.3k
08/24/2023 4 Duey Marc (Director) has filed a Form 4 on Aprea Therapeutics, Inc.
Txns: Converted 4,009,690 shares @ $0
Granted 500 shares @ $0
Converted 11,610 shares @ $0
Converted 400,969 options to buy @ $0
Converted 1,161 options to buy @ $0
Granted 2,000 options to buy @ $3.65, valued at $7.3k
08/24/2023 4 Seizinger Bernd R. (Director) has filed a Form 4 on Aprea Therapeutics, Inc.
Txns: Granted 500 shares @ $0
Granted 2,000 options to buy @ $3.65, valued at $7.3k
08/24/2023 4 BIZZARI JEAN-PIERRE (Director) has filed a Form 4 on Aprea Therapeutics, Inc.
Txns: Granted 12,500 options to buy @ $3.65, valued at $45.6k
08/24/2023 3 BIZZARI JEAN-PIERRE (Director) has filed a Form 3 on Aprea Therapeutics, Inc.
06/08/2023 4 Seizinger Bernd R. (Director) has filed a Form 4 on Aprea Therapeutics, Inc.
Txns: Bought 4,068 shares @ $3.6294, valued at $14.8k
Bought 6,029 shares @ $3.6809, valued at $22.2k
05/08/2023 4 Gruia Gabriela (Director) has filed a Form 4 on Aprea Therapeutics, Inc.
Txns: Granted 12,500 options to buy @ $3.8999, valued at $48.7k
05/08/2023 3 Gruia Gabriela (Director) has filed a Form 3 on Aprea Therapeutics, Inc.
03/13/2023 4 Gilad Oren (President, CEO) has filed a Form 4 on Aprea Therapeutics, Inc.
Txns: Converted 6,045,100 shares @ $0
Granted 4,000 shares @ $0
Converted 604,510 options to buy @ $0
Granted 16,000 options to buy @ $5.08, valued at $81.3k
02/27/2023 4 Hamill John P. (SrVP/CFO/Prin Fin & Acct Ofcr) has filed a Form 4 on Aprea Therapeutics, Inc.
Txns: Granted 1,000 shares @ $5.25, valued at $5.3k
01/30/2023 4 Hamill John P. (SrVP/CFO/Prin. Fin&Acctg. Off) has filed a Form 4 on Aprea Therapeutics, Inc.
Txns: Granted 269,879 shares @ $0
Granted 539,758 options to buy @ $0.496, valued at $267.7k
01/30/2023 3 Hamill John P. (SrVP/CFO/Prin. Fin &Acctg. Off) has filed a Form 3 on Aprea Therapeutics, Inc.
08/01/2022 4 Seizinger Bernd R. (Director) has filed a Form 4 on Aprea Therapeutics, Inc.
Txns: Granted 5,995 shares @ $0
Granted 29,575 options to buy @ $1.09, valued at $32.2k
08/01/2022 4 SCHADE CHRISTIAN S (Director) has filed a Form 4 on Aprea Therapeutics, Inc.
Txns: Granted 32,400 shares @ $0
Granted 47,600 options to buy @ $1.09, valued at $51.9k
08/01/2022 4 Peters Richard (Director) has filed a Form 4 on Aprea Therapeutics, Inc.
Txns: Granted 5,995 shares @ $0
Granted 29,575 options to buy @ $1.09, valued at $32.2k
08/01/2022 4 Pamukcu Rifat (Director) has filed a Form 4 on Aprea Therapeutics, Inc.
Txns: Granted 5,995 shares @ $0
Granted 29,575 options to buy @ $1.09, valued at $32.2k
08/01/2022 4 Korbel Gregory Alan (SVP, COO) has filed a Form 4 on Aprea Therapeutics, Inc.
Txns: Granted 24,300 shares @ $0
Granted 35,700 options to buy @ $1.09, valued at $38.9k
08/01/2022 4 HENNEMAN JOHN B III (Director) has filed a Form 4 on Aprea Therapeutics, Inc.
Txns: Granted 5,995 shares @ $0
Granted 29,575 options to buy @ $1.09, valued at $32.2k
08/01/2022 4 Grissinger Michael (Director) has filed a Form 4 on Aprea Therapeutics, Inc.
Txns: Granted 5,995 shares @ $0
Granted 29,575 options to buy @ $1.09, valued at $32.2k
08/01/2022 4 Gilad Oren (President, CEO) has filed a Form 4 on Aprea Therapeutics, Inc.
Txns: Granted 101,300 shares @ $0
Granted 148,700 options to buy @ $1.09, valued at $162.1k
08/01/2022 4 Duey Marc (Director) has filed a Form 4 on Aprea Therapeutics, Inc.
Txns: Granted 5,995 shares @ $0
Granted 29,575 options to buy @ $1.09, valued at $32.2k
08/01/2022 4 Coiante Scott M (SVP, CFO) has filed a Form 4 on Aprea Therapeutics, Inc.
Txns: Granted 60,800 shares @ $0
Granted 89,200 options to buy @ $1.09, valued at $97.2k
06/07/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/07/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/07/2022 4 Korbel Gregory Alan (SVP, COO) has filed a Form 4 on Aprea Therapeutics, Inc.
Txns: Paid exercise price by delivering 8,390 shares @ $0.805, valued at $6.8k
06/07/2022 4 Attar Eyal C. (SVP, Chief Medical Officer) has filed a Form 4 on Aprea Therapeutics, Inc.
Txns: Paid exercise price by delivering 32,667 shares @ $0.805, valued at $26.3k
05/26/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
05/26/2022 3 Pamukcu Rifat (Director) has filed a Form 3 on Aprea Therapeutics, Inc.
05/26/2022 3 Gilad Oren (President) has filed a Form 3 on Aprea Therapeutics, Inc.
05/26/2022 3 Duey Marc (Director) has filed a Form 3 on Aprea Therapeutics, Inc.
05/19/2022 4 Seizinger Bernd R. (Director) has filed a Form 4 on Aprea Therapeutics, Inc.
Txns: Bought 50,000 shares @ $0.71, valued at $35.5k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy